563 related articles for article (PubMed ID: 27742552)
1. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes.
Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W
J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients.
Zhang L; Guo K; Lu J; Zhao F; Yu H; Han J; Bao Y; Chen H; Jia W
Sci Rep; 2016 May; 6():26805. PubMed ID: 27226159
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.
Kim SK; Choi YJ; Huh BW; Park SW; Lee EJ; Cho YW; Huh KB
J Clin Endocrinol Metab; 2014 May; 99(5):1879-84. PubMed ID: 24512497
[TBL] [Abstract][Full Text] [Related]
4. Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus.
Cho Y; Park HS; Huh BW; Lee YH; Seo SH; Seo DH; Ahn SH; Hong S; Kim SH
Diabetes Metab J; 2023 Mar; 47(2):232-241. PubMed ID: 36653888
[TBL] [Abstract][Full Text] [Related]
5. Decreased urine uric acid excretion is associated with diabetic retinopathy but not with lower limb atherosclerosis in hospitalized patients with type 2 diabetes.
Li LX; Lu JX; Shuai HP; Xia HF; Zhang R; Wang JW; Chen MY; Li TT; Bao YQ; Jia WP
Atherosclerosis; 2015 Sep; 242(1):13-8. PubMed ID: 26162315
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.
Targher G; Bertolini L; Padovani R; Poli F; Scala L; Zenari L; Zoppini G; Falezza G
J Endocrinol Invest; 2006 Jan; 29(1):55-60. PubMed ID: 16553034
[TBL] [Abstract][Full Text] [Related]
7. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
8. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
9. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
[TBL] [Abstract][Full Text] [Related]
10. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
Yu X; Chen C; Guo Y; Tong Y; Zhao Y; Wu L; Sun X; Wu X; Song Z
Ann Med; 2021 Dec; 53(1):1621-1631. PubMed ID: 34498502
[TBL] [Abstract][Full Text] [Related]
11. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
[TBL] [Abstract][Full Text] [Related]
12. Low-normal serum unconjugated bilirubin levels are associated with late but not early carotid atherosclerotic lesions in T2DM subjects.
Jin CH; Wang JW; Ke JF; Li JB; Li MF; Li LX
Front Endocrinol (Lausanne); 2022; 13():948338. PubMed ID: 36407305
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients.
Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Sladoje-Martinovic B; Orlic L
Kidney Blood Press Res; 2014; 39(4):308-14. PubMed ID: 25300437
[TBL] [Abstract][Full Text] [Related]
14. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
[TBL] [Abstract][Full Text] [Related]
16. Prevalence by sex of preclinical carotid atherosclerosis in newly diagnosed type 2 diabetes.
Catalan M; Herreras Z; Pinyol M; Sala-Vila A; Amor AJ; de Groot E; Gilabert R; Ros E; Ortega E
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):742-8. PubMed ID: 26033395
[TBL] [Abstract][Full Text] [Related]
17. Retinal microvascular abnormalities are associated with early carotid atherosclerotic lesions in hospitalized Chinese patients with type 2 diabetes mellitus.
Li LX; Li MF; Lu JX; Jia LL; Zhang R; Zhao CC; Ren Y; Tu YF; Shen Y; Liu F; Bao YQ; Jia WP
J Diabetes Complications; 2014; 28(3):378-85. PubMed ID: 24656691
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study.
Sturlaugsdottir R; Aspelund T; Bjornsdottir G; Sigurdsson S; Thorsson B; Eiriksdottir G; Gudnason V
BMJ Open; 2016 Nov; 6(11):e012457. PubMed ID: 27884845
[TBL] [Abstract][Full Text] [Related]
19. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.
Wang C; Cai Z; Deng X; Li H; Zhao Z; Guo C; Zhang P; Li L; Gu T; Yang L; Zhao L; Wang D; Yuan G
Int J Med Sci; 2021; 18(14):3280-3289. PubMed ID: 34400897
[No Abstract] [Full Text] [Related]
20. Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease.
Petta S; Marrone O; Torres D; Buttacavoli M; Cammà C; Di Marco V; Licata A; Lo Bue A; Parrinello G; Pinto A; Salvaggio A; Tuttolomondo A; Craxì A; Bonsignore MR
PLoS One; 2015; 10(12):e0142210. PubMed ID: 26672595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
